Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (3881)	12/4/2003 9:23:59 AM
From: lostmymoney	Respond to of 23958

Well, IFLO is sitting at 14 now. Did i miss the long boat ride on that one...I sold at 6. You just never know... Cardiac Science, Inc. (Nasdaq: DFIB - News), a leading manufacturer of life-saving automated public access defibrillators (AEDs), today announced that it has closed a number of transactions with leading corporate and government customers that include the purchase of Powerheart G3 AEDs, training and program management services. In aggregate, the sales totaled more than $550,000 Mikey

To: Sergio H who wrote (3881)	12/6/2003 11:31:52 AM
From: Jibacoa	Read Replies (1) \| Respond to of 23958

Sergio: Take a look at OCA for a possible inclusion on the folio.(But not to be followed by me, since you pointed out that I already have two entries.<g>) I think the earnings results for the Dec.Q will be a little better than in 2002 in spite of lower revenues since in 2002 they took almost 2M in "asset impairments" in relation to closing of administration offices. I have it on a watch list since we may see some extra "tax selling" in the next few days.The stock is close to its August L of 6.68 and I don't think it will retest the April L around 4.11 <g> The price (since 1996) had always been above 6. The insiders have done some buying. The stock is selling with a PE of 8, around 0.7 of book and 0.9 of sales with a positive cash flow.<g> I am not long on it as yet, but plan on buying some in spite of it being out of my buying range and not having an appealing chart.<g> bigcharts.marketwatch.com Bernard